SuperworthAquestive Therapeutics shares outstanding AQST
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 125M
- On a year earlier
- +25.8%
- more shares
Aquestive Therapeutics had 125M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 25.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 122M | +34% |
| FY2024 | 91.2M | +36% |
| FY2023 | 67.2M | +24% |
| FY2022 | 54.4M | +35% |
| FY2021 | 40.4M | +19% |
| FY2020 | 33.8M | +28% |
| FY2019 | 26.4M | +6% |
| FY2018 | 24.9M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 125M | +26% | |
| Q1 FY26 | 122.6M | +28% | |
| Q4 FY25 | 122M | +34% | |
| Q3 FY25 | 110.6M | +21% | |
| Q2 FY25 | 99.3M | +9% | |
| Q1 FY25 | 95.5M | +30% | |
| Q4 FY24 | 91.2M | +36% | |
| Q3 FY24 | 91.1M | +41% | |
| Q2 FY24 | 90.9M | +59% | |
| Q1 FY24 | 73.6M | −0% | |
| Q4 FY23 | 67.2M | +24% | |
| Q3 FY23 | 64.7M | +21% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Aquestive Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.